Brigette Ma

20.1k total citations · 4 hit papers
243 papers, 10.2k citations indexed

About

Brigette Ma is a scholar working on Oncology, Otorhinolaryngology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Brigette Ma has authored 243 papers receiving a total of 10.2k indexed citations (citations by other indexed papers that have themselves been cited), including 147 papers in Oncology, 76 papers in Otorhinolaryngology and 69 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Brigette Ma's work include Head and Neck Cancer Studies (76 papers), Viral-associated cancers and disorders (45 papers) and Colorectal Cancer Treatments and Studies (41 papers). Brigette Ma is often cited by papers focused on Head and Neck Cancer Studies (76 papers), Viral-associated cancers and disorders (45 papers) and Colorectal Cancer Treatments and Studies (41 papers). Brigette Ma collaborates with scholars based in Hong Kong, China and United States. Brigette Ma's co-authors include Anthony T.�C. Chan, Edwin P. Hui, Frankie Mo, Benny Zee, Ann D. King, Stephen L. Chan, Tony Mok, Wai Tong Ng, Yuk Ming Dennis Lo and Anne W.M. Lee and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Brigette Ma

235 papers receiving 10.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective

2015 584 citations Brigette Ma, Anthony T.�C. Chan et al. Journal of Clinical Oncology profile →
Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial

2015 553 citations Brigette Ma et al. profile →
Analysis of Plasma Epstein–Barr Virus DNA to Screen for Nasopharyngeal Cancer

2017 501 citations K.C. Allen Chan, John K. S. Woo et al. profile →
Nasopharyngeal carcinoma: an evolving paradigm

2021 315 citations Kenneth C.W. Wong, Edwin P. Hui et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brigette Ma Hong Kong	53	4.9k	3.1k	2.7k	2.4k	2.3k	243	10.2k
Edwin P. Hui Hong Kong	47	4.0k 0.8×	3.2k 1.1×	2.2k 0.8×	2.2k 0.9×	1.8k 0.8×	170	8.9k
George Fountzilas Greece	54	7.7k 1.6×	1.3k 0.4×	3.1k 1.2×	2.1k 0.9×	3.7k 1.6×	576	12.8k
H. Cortés-Funes Spain	44	6.4k 1.3×	976 0.3×	1.8k 0.7×	1.3k 0.5×	2.6k 1.1×	192	9.6k
Frankie Mo Hong Kong	46	3.2k 0.7×	2.7k 0.9×	1.1k 0.4×	1.5k 0.6×	1.8k 0.8×	187	10.3k
Joseph P. Eder United States	47	8.2k 1.7×	588 0.2×	3.4k 1.3×	1.6k 0.7×	3.2k 1.4×	178	12.2k
Laura Q.M. Chow United States	44	9.1k 1.9×	1.2k 0.4×	2.9k 1.1×	1.6k 0.7×	4.6k 2.0×	159	12.4k
Barbara Burtness United States	56	8.5k 1.8×	5.0k 1.6×	4.4k 1.7×	2.4k 1.0×	5.0k 2.1×	363	16.0k
Christophe Le Tourneau France	46	4.9k 1.0×	906 0.3×	2.1k 0.8×	1.6k 0.7×	2.3k 1.0×	335	8.7k
Howard S. Höchster United States	56	8.1k 1.7×	405 0.1×	2.4k 0.9×	1.8k 0.7×	3.3k 1.4×	342	12.0k
George R. Blumenschein United States	60	7.0k 1.4×	482 0.2×	2.7k 1.0×	2.4k 1.0×	5.1k 2.2×	328	12.0k

Countries citing papers authored by Brigette Ma

Since Specialization

Citations

This map shows the geographic impact of Brigette Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brigette Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brigette Ma more than expected).

Fields of papers citing papers by Brigette Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brigette Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brigette Ma. The network helps show where Brigette Ma may publish in the future.

Co-authorship network of co-authors of Brigette Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Brigette Ma. A scholar is included among the top collaborators of Brigette Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brigette Ma. Brigette Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

King, Ann D., Qi Yong H. Ai, W.K. Lam, et al.. (2024). Early detection of nasopharyngeal carcinoma: performance of a short contrast-free screening magnetic resonance imaging. JNCI Journal of the National Cancer Institute. 116(5). 665–672. 6 indexed citations

Ma, Brigette, et al.. (2024). Optimizing Hearing Outcomes in Nasopharyngeal Cancer Survivors in the Era of Modern Radiotherapy and Systemic Therapy. Cancers. 16(18). 3237–3237.

Ai, Qi Yong H., Ann D. King, Zhifeng Yu, et al.. (2024). Predictive markers for head and neck cancer treatment response: T1rho imaging in nasopharyngeal carcinoma. European Radiology. 35(3). 1265–1275. 2 indexed citations

Chantrill, Lorraine A., Hung‐Chih Hsu, Brigette Ma, et al.. (2024). Expert consensus on the optimal management of BRAF^V600E‐mutant metastatic colorectal cancer in the Asia‐Pacific region. Asia-Pacific Journal of Clinical Oncology. 21(1). 31–45. 2 indexed citations

Hui, Connie W. C., Chi Hang Wong, Kwok Wai Lo, et al.. (2023). Preclinical evaluation of the VEGF/Ang2 bispecific nanobody BI 836880 in nasopharyngeal carcinoma models. Investigational New Drugs. 41(5). 699–709. 2 indexed citations

Ai, Qi Yong H., Weitian Chen, Tiffany Y. So, et al.. (2020). Quantitative T1ρ MRI of the Head and Neck Discriminates Carcinoma and Benign Hyperplasia in the Nasopharynx. American Journal of Neuroradiology. 41(12). 2339–2344. 9 indexed citations

Hui, Edwin P., Brigette Ma, W.K. Lam, et al.. (2020). Integrating postradiotherapy plasma Epstein–Barr virus DNA and TNM stage for risk stratification of nasopharyngeal carcinoma to adjuvant therapy. Annals of Oncology. 31(6). 769–779. 72 indexed citations

Hui, Edwin P., Brigette Ma, Herbert H. Loong, et al.. (2018). Efficacy, Safety, and Pharmacokinetics of Axitinib in Nasopharyngeal Carcinoma: A Preclinical and Phase II Correlative Study. Clinical Cancer Research. 24(5). 1030–1037. 41 indexed citations

Ai, Qi Yong H., Ann D. King, Darren M.C. Poon, et al.. (2018). Extranodal extension is a criterion for poor outcome in patients with metastatic nodes from cancer of the nasopharynx. Oral Oncology. 88. 124–130. 54 indexed citations

10.

Rudin, Charles M., Andrés Cervantes, Afshin Dowlati, et al.. (2018). MA15.02 Long-Term Safety and Clinical Activity Results from a Phase Ib Study of Erlotinib Plus Atezolizumab in Advanced NSCLC. Journal of Thoracic Oncology. 13(10). S407–S407. 26 indexed citations

11.

He, Wan, Charles Ming Lok Chan, Sze Chuen Cesar Wong, et al.. (2016). Jagged 2 silencing inhibits motility and invasiveness of colorectal cancer cell lines. Oncology Letters. 12(6). 5193–5198. 8 indexed citations

12.

Hui, Edwin P., Graham S. Taylor, Hui Jia, et al.. (2013). Phase I Trial of Recombinant Modified Vaccinia Ankara Encoding Epstein–Barr Viral Tumor Antigens in Nasopharyngeal Carcinoma Patients. Cancer Research. 73(6). 1676–1688. 146 indexed citations

13.

Wong, Chi Hang, Herbert H. Loong, Connie W. C. Hui, et al.. (2013). Preclinical evaluation of the PI3K-mTOR dual inhibitor PF-04691502 as a novel therapeutic drug in nasopharyngeal carcinoma. Investigational New Drugs. 31(6). 1399–1408. 27 indexed citations

14.

Ma, Brigette, Vivian Wai Yan Lui, Connie W. C. Hui, et al.. (2013). Preclinical evaluation of the mTOR–PI3K inhibitor BEZ235 in nasopharyngeal cancer models. Cancer Letters. 343(1). 24–32. 25 indexed citations

15.

Hui, Edwin P., Brigette Ma, Ann D. King, et al.. (2011). Hemorrhagic complications in a phase II study of sunitinib in patients of nasopharyngeal carcinoma who has previously received high-dose radiation. Annals of Oncology. 22(6). 1280–1287. 81 indexed citations

16.

Lui, Vivian Wai Yan, Elaine Yue Ling Wong, Yeung Ho, et al.. (2009). STAT3 activation contributes directly to Epstein‐Barr virus–mediated invasiveness of nasopharyngeal cancer cells in vitro. International Journal of Cancer. 125(8). 1884–1893. 61 indexed citations

17.

Wong, Sze Chuen Cesar, Charles Ming Lok Chan, Brigette Ma, et al.. (2009). Clinical Significance of Cytokeratin 20-Positive Circulating Tumor Cells Detected by a Refined Immunomagnetic Enrichment Assay in Colorectal Cancer Patients. Clinical Cancer Research. 15(3). 1005–1012. 64 indexed citations

18.

Hui, Edwin P., Brigette Ma, Sing Fai Leung, et al.. (2008). Randomized Phase II Trial of Concurrent Cisplatin-Radiotherapy With or Without Neoadjuvant Docetaxel and Cisplatin in Advanced Nasopharyngeal Carcinoma. Journal of Clinical Oncology. 27(2). 242–249. 406 indexed citations

19.

Yeo, Winnie, Tony Mok, Benny Zee, et al.. (2005). A Randomized Phase III Study of Doxorubicin Versus Cisplatin/Interferon α-2b/Doxorubicin/Fluorouracil (PIAF) Combination Chemotherapy for Unresectable Hepatocellular Carcinoma. JNCI Journal of the National Cancer Institute. 97(20). 1532–1538. 467 indexed citations

20.

Ma, Brigette, June Corry, Danny Rischin, Trevor Leong, & L. J. Peters. (2001). Combined modality treatment for locally advanced squamous-cell carcinoma of the oropharynx in a woman with Bloom’s syndrome: A case report and review of the literature. Annals of Oncology. 12(7). 1015–1017. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact